HCA
TMO icon

Horan Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Horan Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$3.13M Buy
6,294
+34
+0.5% +$18.4K 1.06% 34
2024
Q4 		$3.26M Sell
6,260
-808
-11% -$444K 1.1% 28
2024
Q3 		$4.37M Sell
7,068
-58
-0.8% -$34.3K 1.45% 19
2024
Q2 		$3.94M Sell
7,126
-4
-0.1% -$2.29K 1.38% 21
2024
Q1 		$4.14M Sell
7,130
-106
-1% -$59.5K 1.47% 21
2023
Q4 		$3.84M Sell
7,236
-150
-2% -$72.6K 1.41% 22
2023
Q3 		$3.74M Sell
7,386
-94
-1% -$50.1K 1.5% 24
2023
Q2 		$3.9M Buy
7,480
+32
+0.4% +$17.3K 1.52% 20
2023
Q1 		$4.29M Buy
7,448
+84
+1% +$47.3K 1.77% 15
2022
Q4 		$4.06M Sell
7,364
-3
-0% -$1.59K 1.78% 17
2022
Q3 		$3.74M Buy
7,367
+185
+3% +$104K 1.81% 13
2022
Q2 		$3.9M Buy
7,182
+30
+0.4% +$16.5K 1.81% 12
2022
Q1 		$4.22M Buy
7,152
+55
+0.8% +$31.6K 1.7% 15
2021
Q4 		$4.74M Sell
7,097
-273
-4% -$170K 1.88% 14
2021
Q3 		$4.21M Sell
7,370
-67
-0.9% -$36.8K 1.86% 12
2021
Q2 		$3.75M Sell
7,437
-3,723
-33% -$1.76M 1.69% 16
2021
Q1 		$5.09M Buy
11,160
+262
+2% +$125K 2.44% 8
2020
Q4 		$5.08M Buy
10,898
+50
+0.5% +$23.4K 2.63% 8
2020
Q3 		$4.79M Buy
10,848
+77
+0.7% +$31.8K 2.71% 6
2020
Q2 		$3.9M Sell
10,771
-170
-2% -$57K 2.62% 6
2020
Q1 		$3.1M Buy
10,941
+148
+1% +$46.7K 2.48% 8
2019
Q4 		$3.51M Sell
10,793
-494
-4% -$150K 2.08% 8
2019
Q3 		$3.29M Buy
11,287
+25
+0.2% +$7.16K 2.01% 11
2019
Q2 		$3.31M Sell
11,262
-453
-4% -$125K 2.22% 9
2019
Q1 		$3.21M Sell
11,715
-1,229
-9% -$306K 2.03% 10
2018
Q4 		$2.9M Buy
12,944
+20
+0.2% +$4.69K 1.94% 14
2018
Q3 		$3.15M Sell
12,924
-205
-2% -$47.2K 2.03% 14
2018
Q2 		$2.72M Buy
13,129
+20
+0.2% +$4.25K 1.75% 20
2018
Q1 		$2.71M Sell
13,109
-4,122
-24% -$865K 1.77% 22
2017
Q4 		$3.27M Sell
17,231
-893
-5% -$171K 2.13% 14
2017
Q3 		$3.43M Buy
18,124
+410
+2% +$74.3K 2.11% 12
2017
Q2 		$3.09M Buy
17,714
+335
+2% +$56.3K 2.1% 15
2017
Q1 		$2.67M Buy
17,379
+622
+4% +$95.1K 1.9% 19
2016
Q4 		$2.36M Buy
16,757
+570
+4% +$84K 1.77% 27
2016
Q3 		$2.58M Buy
16,187
+130
+0.8% +$20K 2.04% 17
2016
Q2 		$2.37M Buy
16,057
+160
+1% +$23.6K 1.93% 21
2016
Q1 		$2.25M Buy
15,897
+590
+4% +$79.1K 1.75% 23
2015
Q4 		$2.17M Sell
15,307
-873
-5% -$116K 1.81% 20
2015
Q3 		$1.98M Buy
16,180
+690
+4% +$89.9K 1.66% 25
2015
Q2 		$2.01M Buy
15,490
+605
+4% +$78.9K 1.69% 32
2015
Q1 		$2M Buy
14,885
+385
+3% +$49.6K 1.67% 32
2014
Q4 		$1.82M Sell
14,500
-3,817
-21% -$464K 1.5% 39
2014
Q3 		$2.23M Buy
18,317
+2,436
+15% +$296K 1.97% 17
2014
Q2 		$1.87M Buy
15,881
+3,020
+23% +$355K 1.71% 22
2014
Q1 		$1.55M Buy
12,861
+406
+3% +$48.3K 1.49% 31
2013
Q4 		$1.39M Sell
12,455
-60
-0.5% -$5.97K 1.42% 34
2013
Q3 		$1.15M Buy
12,515
+350
+3% +$31.7K 1.37% 34
2013
Q2 		$1.03M Buy
+12,165
New +$1.01M 1.57% 30

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Horan Capital Advisors's TMO Position: Q1 2025 in Review

Horan Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 0.54% in Q1 2025, buying an estimated $18.4K and bringing the position to 6,294 shares worth $3.13M. The position accounts for 1.06% of the portfolio, ranked #34.

Horan Capital Advisors first reported a position in TMO in Q2 2013 and has held it in 48 quarters since. The position peaked at $5.09M in Q1 2021. 2,572 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Horan Capital Advisors held 6,294 shares of Thermo Fisher Scientific worth $3.13M as of Q1 2025.
  • Horan Capital Advisors bought 34 Thermo Fisher Scientific shares in Q1 2025, an estimated $18.4K.
  • Thermo Fisher Scientific made up 1.06% of Horan Capital Advisors's portfolio in Q1 2025, its #34 holding.
  • Horan Capital Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 48 quarters since.
  • Horan Capital Advisors's Thermo Fisher Scientific position peaked at $5.09M in Q1 2021.
  • 2,572 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Horan Capital Advisors's 13F filing for Q1 2025, filed 7 May 2025.